CymitQuimica logo
Angiogénese

Angiogénese

Os inibidores da angiogênese são compostos que interferem na formação de novos vasos sanguíneos, um processo crítico no crescimento e metástase do câncer. Ao inibir a angiogênese, esses compostos podem restringir o suprimento de sangue para os tumores, retardando ou interrompendo seu crescimento. Os inibidores da angiogênese são essenciais na pesquisa do câncer e no desenvolvimento terapêutico, fornecendo insights sobre os mecanismos de progressão tumoral e oferecendo potenciais tratamentos para o câncer e outras doenças relacionadas à angiogênese. Na CymitQuimica, oferecemos uma ampla gama de inibidores da angiogênese de alta qualidade para apoiar sua pesquisa em oncologia e biologia vascular.

Subcategorias de "Angiogénese"

Exibir 6 mais subcategorias

Foram encontrados 2061 produtos de "Angiogénese"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
produtos por página.
  • FLT3-IN-18

    CAS:
    FLT3-IN-18: potent, selective FLT3 inhibitor, IC50 0.003 μM, induces apoptosis, G1 arrest, blocks FLT3/STAT5, potential in AML research.
    Fórmula:C26H36N8O
    Cor e Forma:Solid
    Peso molecular:476.62
  • Antiproliferative agent-34

    CAS:
    Antiproliferative Agent-34 (Compound A14), a multitarget kinase inhibitor, demonstrates IC50 values of 177 nM for EGFR L858R/T790M and 1567 nM for EGFR WT.
    Fórmula:C27H27N7O5
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:529.55
  • MS 154N

    CAS:
    <p>MS 154N is a negative control for MS 154, binds WT/L858R EGFR tightly (Kd 3-4.3nM), doesn't trigger mutant EGFR degradation.</p>
    Fórmula:C47H56ClFN8O8
    Cor e Forma:Solid
    Peso molecular:915.45
  • c-ABL-IN-2

    CAS:
    C-ABL-IN-2 is a potent c-Abl protein inhibitor, promising for research in cancer and neurodegenerative diseases like ALS and PD.
    Fórmula:C21H20N4O
    Cor e Forma:Solid
    Peso molecular:344.41
  • DBPR112

    CAS:
    DBPR112: oral furanopyrimidine EGFR inhibitor; IC50: 15 nM (EGFRWT), 48 nM (L858R/T790M); blocks ATP site, strong antitumor effects.
    Fórmula:C32H31N5O3
    Pureza:99.25%
    Cor e Forma:Solid
    Peso molecular:533.62
  • EGFR/HER2-IN-3

    CAS:
    EGFR/HER2-IN-3 (Compound ZINC21942954) is a dual EGFR and HER2 inhibitor.
    Fórmula:C26H23N5O3
    Cor e Forma:Solid
    Peso molecular:453.49
  • VEGFR-2-IN-27

    CAS:
    VEGFR-2-IN-27 (compound 7a) is a potent inhibitor of VEGFR-2 (IC50: 14.8 nM) and can be used in anticancer studies.
    Fórmula:C25H21FN4O4
    Cor e Forma:Solid
    Peso molecular:460.46
  • Sitravatinib malate

    CAS:
    <p>Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5</p>
    Fórmula:C37H35F2N5O9S
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:763.76
  • MTX-531

    CAS:
    MTX-531 is a selective inhibitor of EGFR and PI3K with IC50 of 14.7   nM and 1.1-233  nM (PI3Kα, PI3Kβ...), respectively. It also acts as a weak agonist of PPARγ, with an EC50 of 3.4 μM in 293H cells.
    Fórmula:C22H20ClN5O2S
    Cor e Forma:Soild
    Peso molecular:453.94
  • RSH-7

    CAS:
    RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing
    Fórmula:C22H25FN8O
    Pureza:99.43%
    Cor e Forma:Solid
    Peso molecular:436.49
  • KRN383

    CAS:
    KRN383 inhibits ITD cell growth at ≤2.9 nM, erases ITD tumors in mice at 80 mg/kg dose, and may suit various treatment plans.
    Fórmula:C17H17N3O4
    Cor e Forma:Solid
    Peso molecular:327.33
  • R-932348 choline

    CAS:
    R-932348 choline, a dual JAK/SYK inhibitor, is used potentially for treatment of dry eye disease.
    Fórmula:C28H35FN6O5S
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:586.68
  • JNJ-47117096 hydrochloride

    CAS:
    JNJ-47117096 hydrochloride is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM.
    Fórmula:C21H23ClN4O2
    Cor e Forma:Solid
    Peso molecular:398.89
  • TYK2-IN-11

    CAS:
    TYK2-IN-11 (5B) selectively inhibits TYK2 (IC50: 0.016 nM) and JAK1 (IC50: 0.31 nM), aiding autoimmune and inflammatory disease research.
    Fórmula:C18H17N5O3S
    Cor e Forma:Solid
    Peso molecular:383.42
  • FAK inhibitor 5

    CAS:
    FAK inhibitor 5 is a novel allosteric FAK inhibitor, with IC50 values in the low micromolar range.
    Fórmula:C20H21N3O2S
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:367.46
  • SUN13837

    CAS:
    SUN13837, an oral FGFR modulator, crosses the BBB and shows neuroprotective promise.
    Fórmula:C21H29N5O2
    Cor e Forma:Solid
    Peso molecular:383.49
  • JAK-2/3-IN-2

    CAS:
    JAK-2/3-IN-2 (Compound 3h) is a potent JAK2 & JAK3 inhibitor with IC50s of 23.85 nM (JAK2) & 18.9 nM (JAK3).
    Fórmula:C19H19ClN2OS
    Cor e Forma:Solid
    Peso molecular:358.89
  • MAX-40279 hemifumarate

    CAS:
    <p>MAX-40279 hemifumarate inhibits FLT3 and FGFR kinases, showing promise for AML treatment.</p>
    Fórmula:C48H50F2N12O6S2
    Cor e Forma:Solid
    Peso molecular:993.12
  • LBW242

    CAS:
    LBW242: oral 3-mer Smac mimetic, IAP inhibitor, targets multiple myeloma, enhances TRAIL/chemo death in ovarian cancer, active on mutant FLT3 cells.
    Fórmula:C27H42N4O2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:454.65
  • Squarunkin A hydrochloride

    CAS:
    Squarunkin A HCl inhibits UNC119-cargo binding, specifically blocks Src kinase activation, IC50=10 nm.
    Fórmula:C25H33ClF3N5O4
    Cor e Forma:Soild
    Peso molecular:560.02